Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00617409 · ClinicalTrials.gov registry record · Phase 2

To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid

A Phase 2 study of Small-cell Lung Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
Phase 2
Development phase
69
Enrollment target
1
Study location

NCT00617409 is a Phase 2 study of Small-cell Lung Cancer that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 69 participants, below the 231-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00617409, a Phase 2 study of Small-cell Lung Cancer, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
Phase 2
Development phase
69 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to test a tumor (cancer) vaccine given along with chemotherapy to determine if this vaccine will increase the chances of the tumor shrinking and/or the amount of time that people who have this disease will live.

Conditions Studied

Small-cell Lung Cancer

Interventions

  • DRUG Paclitaxel
  • BIOLOGICAL Drug: Ad.p53-DC vaccines
  • DRUG All -trans Retinoic Acid (ATRA)

Study Locations (1)

Florida

  • H. Lee Moffitt Cancer Center & Research Institute - Tampa

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2007-10-02
Est. Completion 2019-01-31
Phase Phase 2

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

502 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00617409

The ClinicalTrials.gov registry entry for NCT00617409 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (70% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Small-cell Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which Paclitaxel is the first listed.

NCT00617409 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00617409 about?

NCT00617409 is a clinical study titled "To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid". The purpose of this research study is to test a tumor (cancer) vaccine given along with chemotherapy to determine if this vaccine will increase the chances of the tumor shrinking and/or the amount of time that people who have this disease will live.

What is the current status of trial NCT00617409?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 2007-10-02. Estimated completion is 2019-01-31.

What conditions does trial NCT00617409 study?

This clinical trial studies the following conditions: Small-cell Lung Cancer.

What interventions are being tested in trial NCT00617409?

The interventions under investigation include: Paclitaxel (DRUG), Drug: Ad.p53-DC vaccines (BIOLOGICAL), All -trans Retinoic Acid (ATRA) (DRUG).

Who is sponsoring clinical trial NCT00617409?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00617409 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Small-cell Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Small-cell Lung Cancer

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.